Accès gratuit
Numéro
Med Sci (Paris)
Volume 20, Numéro 11, Novembre 2004
Page(s) 1014 - 1019
Section M/S revues
DOI https://doi.org/10.1051/medsci/200420111014
Publié en ligne 15 novembre 2004
  1. Gisselbrecht S. Oncogenes and leukemia : history and perspectives. Med Sci (Paris) 2003; 19 : 201–10. [Google Scholar]
  2. Boyd KE, Farnham PJ. Identification of target genes of oncogenic transcription factors. Proc Soc Exp Biol Med 1999; 222 : 9–28. [Google Scholar]
  3. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278 : 1059–64. [Google Scholar]
  4. Dittmer J, Nordheim A. Ets transcription factors and human disease. Biochim Biophys Acta 1998; 1377 : F1–11. [Google Scholar]
  5. Galiana-Arnoux D, Lejeune F, Gesnel MC, et al. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. J Biol Chem 2003; 278 : 32943–53. [Google Scholar]
  6. Caballero OL, de Souza SJ, Brentani RR, Simpson AJ. Alternative spliced transcripts as cancer markers. Dis Markers 2001; 17 : 67–75. [Google Scholar]
  7. Knoop LL, Baker SJ. The splicing factor U1C represses EWS/FLI-mediated transactivation. J Biol Chem 2000; 275 : 24865–71. [Google Scholar]
  8. Poleev A, Hartmann A, Stamm S. A trans-acting factor, isolated by the three-hybrid system, that influences alternative splicing of the amyloid precursor protein minigene. Eur J Biochem 2000; 267 : 4002–10. [Google Scholar]
  9. Yang L, Embree LJ, Hickstein DD. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 2000; 20 : 3345–54. [Google Scholar]
  10. Knoop LL, Baker SJ. EWS/FLI alters 5’-splice site selection. J Biol Chem 2001; 276 : 22317–22. [Google Scholar]
  11. Yang L, Chansky HA, Hickstein DD. EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J Biol Chem 2000; 275 : 37612–8. [Google Scholar]
  12. Chansky HA, Hu M, Hickstein DD, Yang L. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res 2001; 61 : 3586–90. [Google Scholar]
  13. Moreau-Gachelin F, Wendling F, Molina T, et al. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol 1996; 16 : 2453–63. [Google Scholar]
  14. Starck J, Doubeikovski A, Sarrazin S, et al. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines. Mol Cell Biol 1999; 19 : 121–35. [Google Scholar]
  15. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis : an affair involving multiple partners. Oncogene 2002; 21 : 3368–76. [Google Scholar]
  16. Hallier M, Tavitian A, Moreau-Gachelin F. The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb. J Biol Chem 1996; 271 : 11177–81. [Google Scholar]
  17. Hallier M, Lerga A, Barnache S, et al. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J Biol Chem 1998; 273 : 4838–42. [Google Scholar]
  18. Deguillien M, Huang SC, Morinière M, et al. Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood 2001; 98 : 3809–16. [Google Scholar]
  19. Théoleyre O, Deguillien M, Morinière M, et al. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells. Oncogene 2004; 23 : 920–7. [Google Scholar]
  20. Orphanides G, Reinberg D. A unified theory of gene expression. Cell 2002; 108 : 439–51. [Google Scholar]
  21. Nogues G, Kadener S, Cramer P, et al. Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem 2002; 277 : 43110–4. [Google Scholar]
  22. Kadener S, Fededa JP, Rosbash M, Kornblihtt AR. Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation. Proc Natl Acad Sci USA 2002; 99 : 8185–90. [Google Scholar]
  23. Furger A, O’Sullivan JM, Binnie A, et al. Promoter proximal splice sites enhance transcription. Genes Dev 2002; 16 : 2792–9. [Google Scholar]
  24. Kwek KY, Murphy S, Furger A, et al. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat Struct Biol 2002; 9 : 800–5. [Google Scholar]
  25. Ge H, Si Y, Wolffe AP. A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol Cell 1998; 2 : 751–9. [Google Scholar]
  26. Fong YW, Zhou Q. Stimulatory effect of splicing factors on transcriptional elongation. Nature 2001; 414 : 929–33. [Google Scholar]
  27. Tian H. RNA ligands generated against complex nuclear targets indicate a role for U1 snRNP in co-ordinating transcription and RNA splicing. FEBS Lett 2001; 509 : 282–6. [Google Scholar]
  28. Lai MC, Teh BH, Tarn WY. A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J Biol Chem 1999; 274 : 11832–41. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.